Mirtazapine Treatment for Comorbid Anxiety/Depressive Disorders in Young Subjects with Attention-Deficit Hyperactivity Disorder: Case Series

Coskun M., AHMETOĞLU E., Ozturk M.

KLINIK PSIKOFARMAKOLOJI BULTENI-BULLETIN OF CLINICAL PSYCHOPHARMACOLOGY, cilt.20, sa.3, ss.246-251, 2010 (SCI-Expanded) identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 20 Sayı: 3
  • Basım Tarihi: 2010
  • Doi Numarası: 10.1080/10177833.2010.11790666
  • Dergi Adı: KLINIK PSIKOFARMAKOLOJI BULTENI-BULLETIN OF CLINICAL PSYCHOPHARMACOLOGY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), TR DİZİN (ULAKBİM)
  • Sayfa Sayıları: ss.246-251
  • Anahtar Kelimeler: Anxiety, ADHD, depression, comorbidity, mirtazapine, treatment, DEFICIT/HYPERACTIVITY DISORDER, OPEN-LABEL, PSYCHIATRIC COMORBIDITY, SLEEP PROBLEMS, CHILDREN, ANXIETY, ADOLESCENTS, ATOMOXETINE, DEPRESSION, FLUOXETINE
  • İstanbul Üniversitesi Adresli: Hayır

Özet

Objective: To investigate the efficacy and tolerability of mirtazapine combination with methylphenidate in young subjects with diagnosis of attention deficit hyperactivity disorder (ADHD) and comorbid anxiety or depressive disorders.